Mesirow Institutional Investment Management’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-761,282
Closed -$11.7M 135
2024
Q2
$11.7M Sell
761,282
-52,632
-6% -$752K 1.03% 51
2024
Q1
$12M Sell
813,914
-23,688
-3% -$328K 1.07% 48
2023
Q4
$12M Buy
837,602
+132
+0% +$1.88K 1.12% 48
2023
Q3
$11.7M Sell
837,470
-182,500
-18% -$2.33M 1.18% 33
2023
Q2
$12M Buy
1,019,970
+299,940
+42% +$3.41M 1.24% 32
2023
Q1
$8.28M Buy
720,030
+72,320
+11% +$895K 0.9% 56
2022
Q4
$8.05M Sell
647,710
-144,320
-18% -$1.84M 1.06% 53
2022
Q3
$10.4M Buy
+792,030
New +$11.7M 1.51% 17

Other funds holding SBRA

Mesirow Institutional Investment Management's SBRA Position: Q3 2024 in Review

Mesirow Institutional Investment Management sold out of Sabra Healthcare REIT (SBRA) in Q3 2024, closing a stake of 761,282 shares — an estimated $11.7M sold.

Mesirow Institutional Investment Management first reported a position in SBRA in Q3 2022 and held it in 8 quarters. The position peaked at $12M in Q1 2024. 379 funds tracked by Wall St. Rank hold SBRA as of Q3 2024.

  • Mesirow Institutional Investment Management reported no remaining Sabra Healthcare REIT position as of Q3 2024 after selling out during the quarter.
  • Mesirow Institutional Investment Management sold 761,282 Sabra Healthcare REIT shares in Q3 2024, an estimated $11.7M.
  • Mesirow Institutional Investment Management first reported a position in Sabra Healthcare REIT in Q3 2022 and held it in 8 quarters.
  • Mesirow Institutional Investment Management's Sabra Healthcare REIT position peaked at $12M in Q1 2024.
  • 379 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q3 2024.

Based on Mesirow Institutional Investment Management's 13F filing for Q3 2024, filed 13 Nov 2024.